Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced ...

Precision BioSciences, Inc.’s DTIL share price has dipped by 9.90%, which has investors questioning if this is right time to ...

Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...

WXII 12 News will hold a Community Blood Drive on Thursday, May 29, at College Park Baptist Church Gym located at 1701 Polo ...

Qiagen has a relatively well-diversified portfolio across four segments. Find out my recommendation on QGEN stock here.

Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the ...

The global Point Of Care Diagnostics Market is projected to be valued at USD 47.8 billion in 2024 and reach USD 68.5 billion by 2030, growing at a CAGR of 6.1% according to a new report by The ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw155 ...

General and administrative (G&A) expenses were $12.4 million for the first quarter of 2025, which included $5.1 million of restructuring expenses in March 2025. Non-cash stock-based compensation ...

Enrollment open in investigator-sponsored trial (IST) of NKX019 in myasthenia gravis; Ntrust-1, Ntrust-2, and IST of NKX019 in systemic lupus erythematosus remain open to enrollment Ntrust-1 expanded ...

The Catholic Medical Center of Catholic University has taken a meaningful first step in the treatment of osteoarthritis.